Acceptability of treatment of latent tuberculosis infection in newly HIV-infected young women in Uganda [Notes from the field]
Abstract:We studied the acceptability of isoniazid preventive therapy (IPT) in newly human immunodeficiency virus (HIV) infected Ugandan women. Women were followed in an out-patient clinic where they received HIV care including IPT. Of 52 women who were purified protein derivative-positive, 48 were eligible for IPT and 39 (81%) completed therapy. This completion rate was higher than reported in similar observational studies.
Document Type: Short Communication
Affiliations: 1: Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio, USA 2: Behavioral and Biomedical Research Division, Family Health International, Research Triangle Park, North Carolina, USA 3: Department of Obstetrics and Gynaecology, Makerere University College of Health Sciences, Mulago Hospital, Kampala, Uganda 4: Case Western Reserve University Research Collaboration, Makerere University College of Health Sciences, Mulago Hospital, Kampala, Uganda 5: Joint Clinical Research Centre, Kampala, Uganda 6: Department of Epidemiology and Biostatistics, School of Public Health, Makerere University, Kampala, Uganda
Publication date: December 1, 2010
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.
Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites